Dashemani Gana ↔ Therapeutic Drug Classification

Charaka's fifty groups of ten drugs each classify five hundred drugs by therapeutic action rather than botanical family -- the same organizing logic modern pharmacology uses for classes like beta-blockers -- though gana membership is a classical clinical claim rather than demonstrated efficacy.

IN PLAIN LANGUAGE

Charaka grouped five hundred classical drugs into fifty 'families of ten,' not by which plant they come from but by what they do -- ten drugs that promote life, ten for skin disease, ten for fever. Modern medicine organizes its drugs the same way -- beta-blockers, antibiotics, antihypertensives grouped by action, not chemical origin -- making the two systems structurally similar even though the underlying evidence differs completely.

Ayurveda offers a broad, memorable, action-organized index across its entire classical materia medica, useful for selection and substitution within the tradition. Modern pharmacology offers therapeutic classes built on demonstrated mechanism and trial evidence -- the standard a classical gana-membership claim would need to meet before being treated as proven efficacy.

WHEN TO SEEK CARE

Not a symptom-specific topic; care-seeking depends on the condition being treated, not the classification system itself.

🔴 REFER IMMEDIATELY

Not applicable at the concept level -- safety depends on the specific drug and condition, not the classification framework
A serious or worsening condition being managed solely on the basis of a drug's classical gana membership without modern evidence of efficacy for that condition

Never do this

Do not treat membership in a Dashemani gana as modern evidence of efficacy -- it documents a classical clinical claim, not a demonstrated pharmacological effect -- and do not substitute an ashtavarga-identified drug or other disputed-identity plant without knowing whether what is available is the true classical drug or an accepted substitute.

🟢 SUITABLE FOR ROUTINE / COLLABORATIVE CARE

AYURVEDA SCOPE

Using gana membership as a starting index to select among options within a well-established, safety-vetted classical drug group, and as a rationale for substitution when a specific drug is unavailable.

MODERN MEDICINE SCOPE

Establishing a drug class's efficacy and safety through pharmacological and clinical trial evidence before it is relied upon for a specific indication.

COLLABORATIVE SCOPE

Treating gana membership as a lead for further investigation rather than proof of efficacy, particularly for serious conditions, and being aware that several classical plant identities within key ganas (e.g., the ashtavarga in jeevaniya) are disputed or substituted.

Sign in to read the full comparison

The plain-language summary and safety guidance above are free for everyone. The 10-dimension scholarly comparison needs an account.